Back to
Point72 Asset Management, L.P.
VRDN
Showing 8 of 20 quarters
Position history for
Point72 Asset Management, L.P.'s holdings in VIRIDIAN THERAPEUTICS INC
Yes. Point72 Asset Management holds 2,343,208 shares of VRDN (Viridian Therapeutics), worth $43M, as of its Q2 2026 13F filing. It increased the position from 322,836 shares in Q1 2026. Point72 Asset Management has held VRDN since Q4 2025, across 3 quarterly 13F filings.
Current Value
$43M
Current Shares
2.3M
Total Value Change
+$42.3M
Total Shares Change
+2.3M
Quarter-by-Quarter History